Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract. Current Pharmaceutical Design (2011)
Structured dietary changes, regular physical activity, stress reduction, and sleep optimization can produce meaningful results without pharmacologic risk
GLP-1 drugs connected to rare vision issue, researchers say (NewsNation) A serious but rare eye condition is one of the newest possible risks for GLP-1 drug users, according to new research
In moving toward a systems level understanding of the MGBA and leveraging advances in microbiome science-the LBPs-it is all possible to usher in a new era of preventive and therapeutic agendas toward complex neuropsychiatric and neurodegenerative disorders
Vitamin C could offer benefits for people diagnosed with gout because it may help reduce uric acid in the blood
Patients can use HSA or FSA funds to cover treatment costs, making precision GLP-1 therapy accessible alongside ongoing thyroid care